Real-World Evidence/RWE Solutions Market is expected to increase at a CAGR of 8.5%.
The Real-World Evidence (RWE) Solutions Market is experiencing substantial growth, driven by increasing regulatory support, rising R&D investments, and the shift towards value-based healthcare systems. RWE solutions are crucial for providing data on the safety, effectiveness, and value of medical products by utilizing real-world data from electronic health records, claims, and patient registries. While traditionally used for post-approval safety surveillance, recent trends show RWE’s integration into earlier stages of drug development and throughout the entire drug lifecycle.